Cargando…

MUC1 Expression by Immunohistochemistry Is Associated with Adverse Pathologic Features in Prostate Cancer: A Multi-Institutional Study

BACKGROUND: The uncertainties inherent in clinical measures of prostate cancer (CaP) aggressiveness endorse the investigation of clinically validated tissue biomarkers. MUC1 expression has been previously reported to independently predict aggressive localized prostate cancer. We used a large cohort...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eminaga, Okyaz, Wei, Wei, Hawley, Sarah J., Auman, Heidi, Newcomb, Lisa F., Simko, Jeff, Hurtado-Coll, Antonio, Troyer, Dean A., Carroll, Peter R., Gleave, Martin E., Lin, Daniel W., Nelson, Peter S., Thompson, Ian M., True, Lawrence D., McKenney, Jesse K., Feng, Ziding, Fazli, Ladan, Brooks, James D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5112958/ https://www.ncbi.nlm.nih.gov/pubmed/27846218 http://dx.doi.org/10.1371/journal.pone.0165236

Ejemplares similares

Evaluation of ERG and SPINK1 by Immunohistochemical Staining and Clinicopathological Outcomes in a Multi-Institutional Radical Prostatectomy Cohort of 1067 Patients
por: Brooks, James D., et al.
Publicado: (2015)

Boolean analysis identifies CD38 as a biomarker of aggressive localized prostate cancer
por: Sahoo, Debashis, et al.
Publicado: (2018)

Analytic Validation of a Clinical-Grade PTEN Immunohistochemistry Assay in Prostate Cancer by Comparison to PTEN FISH
por: Lotan, Tamara L., et al.
Publicado: (2016)

A multicenter study shows PTEN deletion is strongly associated with seminal vesicle involvement and extracapsular extension in localized prostate cancer
por: Troyer, Dean A, et al.
Publicado: (2015)

Analysis of separate training and validation radical prostatectomy cohorts identifies 0.25 mm diameter as an optimal definition for “large” cribriform prostatic adenocarcinoma
por: Chan, Emily, et al.
Publicado: (2022)

Prostate Stromal Cells Express the Progesterone Receptor to Control Cancer Cell Mobility
por: Yu, Yue, et al.
Publicado: (2014)

Quality control in molecular immunohistochemistry
por: True, Lawrence D.
Publicado: (2008)

CMDX©-based single source information system for simplified quality management and clinical research in prostate cancer
por: Eminaga, Okyaz, et al.
Publicado: (2012)

Combined EsophaCap cytology and MUC2 immunohistochemistry for screening of intestinal metaplasia, dysplasia and carcinoma
por: Zhou, Zhongren, et al.
Publicado: (2019)

Artificial Intelligence-Based Prognostic Model for Urologic Cancers: A SEER-Based Study
por: Eminaga, Okyaz, et al.
Publicado: (2022)

MUC4 immunohistochemistry is useful in distinguishing epithelioid mesothelioma from adenocarcinoma and squamous cell carcinoma of the lung
por: Mawas, Amany Sayed, et al.
Publicado: (2018)

Clinical map document based on XML (cMDX): document architecture with mapping feature for reporting and analysing prostate cancer in radical prostatectomy specimens
por: Eminaga, Okyaz, et al.
Publicado: (2010)

A prognostic score for overall survival in patients treated with abiraterone in the pre- and post-chemotherapy setting
por: Boegemann, Martin, et al.
Publicado: (2019)

Artificial Intelligence Reveals Distinct Prognostic Subgroups of Muscle-Invasive Bladder Cancer on Histology Images
por: Eminaga, Okyaz, et al.
Publicado: (2023)

Novel lincRNA SLINKY is a prognostic biomarker in kidney cancer
por: Gong, Xue, et al.
Publicado: (2017)

Conceptual Framework and Documentation Standards of Cystoscopic Media Content for Artificial Intelligence
por: Eminaga, Okyaz, et al.
Publicado: (2023)

MUC1, MUC2, MUC5AC, and MUC6 in colorectal cancer: expression profiles and clinical significance
por: Betge, Johannes, et al.
Publicado: (2016)

Loss of Nuclear Functions of HOXA10 Is Associated With Testicular Cancer Proliferation
por: Chen, Ruiqi, et al.
Publicado: (2018)

Catheterless Long-Term Ambulatory Urodynamic Measurement Using a Novel Three-Device System
por: Wille, Sebastian, et al.
Publicado: (2014)

Dynamic changes of alkaline phosphatase are strongly associated with PSA-decline and predict best clinical benefit earlier than PSA-changes under therapy with abiraterone acetate in bone metastatic castration resistant prostate cancer
por: Mikah, Phillip, et al.
Publicado: (2016)

A Gastric Glycoform of MUC5AC Is a Biomarker of Mucinous Cysts of the Pancreas
por: Sinha, Jessica, et al.
Publicado: (2016)

The zinc-finger bearing xenogeneic silencer MucR in α-proteobacteria balances adaptation and regulatory integrity
por: Jiao, Jian, et al.
Publicado: (2021)

Regulation of c-Myc expression by the histone demethylase JMJD1A is essential for prostate cancer cell growth and survival
por: Fan, Lingling, et al.
Publicado: (2015)

Identification of DEK as a potential therapeutic target for neuroendocrine prostate cancer
por: Lin, Dong, et al.
Publicado: (2014)

BIRC6 Protein, an Inhibitor of Apoptosis: Role in Survival of Human Prostate Cancer Cells
por: Low, Christopher G., et al.
Publicado: (2013)

GATA2 as a potential metastasis-driving gene in prostate cancer
por: Chiang, Yan Ting, et al.
Publicado: (2014)

Expression of KOC, S100P, mesothelin and MUC1 in pancreatico-biliary adenocarcinomas: development and utility of a potential diagnostic immunohistochemistry panel
por: Ali, Asif, et al.
Publicado: (2014)

Association of TMPRSS2-ERG gene fusion with clinical characteristics and outcomes: results from a population-based study of prostate cancer
por: FitzGerald, Liesel M, et al.
Publicado: (2008)

Characterization of a Prostate- and Prostate Cancer-Specific Circular RNA Encoded by the Androgen Receptor Gene
por: Luo, Jindan, et al.
Publicado: (2019)

Inhibition of Pten deficient Castration Resistant Prostate Cancer by Targeting of the SET - PP2A Signaling axis
por: Hu, Xiaoyong, et al.
Publicado: (2015)

Downregulation of c-SRC kinase CSK promotes castration resistant prostate cancer and pinpoints a novel disease subclass
por: Yang, Chih-Cheng, et al.
Publicado: (2015)

Long term deficiency of vitamin D in germ cell testicular cancer survivors
por: Nappi, Lucia, et al.
Publicado: (2018)

MUC (Memory, Unification, Control) and beyond
por: Hagoort, Peter
Publicado: (2013)

The BIRC6 gene as a novel target for therapy of prostate cancer: dual targeting of inhibitors of apoptosis
por: Iris Luk, Sze Ue, et al.
Publicado: (2014)

Germline mutations in penetrant cancer predisposition genes are rare in men with prostate cancer selecting active surveillance
por: Brady, Lauren, et al.
Publicado: (2022)

Clusterin facilitates stress-induced lipidation of LC3 and autophagosome biogenesis to enhance cancer cell survival
por: Zhang, Fan, et al.
Publicado: (2014)

Expression of MUC1 and MUC4 in Gallbladder Adenocarcinoma
por: Kim, Su-Mi, et al.
Publicado: (2012)

MUC1 Vaccines, Comprised of Glycosylated or Non-Glycosylated Peptides or Tumor-Derived MUC1, Can Circumvent Immunoediting to Control Tumor Growth in MUC1 Transgenic Mice
por: Lakshminarayanan, Vani, et al.
Publicado: (2016)

Drosophila Pupal Abdomen Immunohistochemistry
por: Wang, Wei, et al.
Publicado: (2011)

Differential Expression of MUC12, MUC16, and MUC20 in Patients with Active and Remission Ulcerative Colitis
por: Yamamoto-Furusho, Jesús K., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_5n9vhpn4lpa2kp63ukqjrs9nc5